185 related articles for article (PubMed ID: 32238816)
1. Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls.
Goldsmith DR; Massa N; Pearce BD; Wommack EC; Alrohaibani A; Goel N; Cuthbert B; Fargotstein M; Felger JC; Haroon E; Miller AH; Duncan E
NPJ Schizophr; 2020 Apr; 6(1):8. PubMed ID: 32238816
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder.
Goldsmith DR; Haroon E; Woolwine BJ; Jung MY; Wommack EC; Harvey PD; Treadway MT; Felger JC; Miller AH
Brain Behav Immun; 2016 Aug; 56():281-8. PubMed ID: 27040122
[TBL] [Abstract][Full Text] [Related]
3. The association between cytokines and psychomotor speed in a spectrum of psychotic disorders: A longitudinal study.
Larsen JB; Reitan SK; Løberg EM; Rettenbacher M; Bruserud Ø; Larsen TK; Anda L; Bartz-Johannessen C; Johnsen E; Kroken RA
Brain Behav Immun Health; 2021 Dec; 18():100392. PubMed ID: 34877553
[TBL] [Abstract][Full Text] [Related]
4. Psychomotor slowing and planning deficits in schizophrenia.
Jogems-Kosterman BJ; Zitman FG; Van Hoof JJ; Hulstijn W
Schizophr Res; 2001 Mar; 48(2-3):317-33. PubMed ID: 11295384
[TBL] [Abstract][Full Text] [Related]
5. The effects of atypical and conventional antipsychotics on reduced processing speed and psychomotor slowing in schizophrenia: a cross-sectional exploratory study.
Morrens M; Hulstijn W; Sabbe B
Clin Ther; 2008 Apr; 30(4):684-92. PubMed ID: 18498917
[TBL] [Abstract][Full Text] [Related]
6. More than just tapping: index finger-tapping measures procedural learning in schizophrenia.
Da Silva FN; Irani F; Richard J; Brensinger CM; Bilker WB; Gur RE; Gur RC
Schizophr Res; 2012 May; 137(1-3):234-40. PubMed ID: 22341487
[TBL] [Abstract][Full Text] [Related]
7. Psychomotor and cognitive deficits as predictors of 5-year outcome in first-episode schizophrenia.
Bodén R; Abrahamsson T; Holm G; Borg J
Nord J Psychiatry; 2014 May; 68(4):282-8. PubMed ID: 24050122
[TBL] [Abstract][Full Text] [Related]
8. Parsing the components of the psychomotor syndrome in schizophrenia.
Docx L; Morrens M; Bervoets C; Hulstijn W; Fransen E; De Hert M; Baeken C; Audenaert K; Sabbe B
Acta Psychiatr Scand; 2012 Oct; 126(4):256-65. PubMed ID: 22360494
[TBL] [Abstract][Full Text] [Related]
9. Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study.
Frydecka D; Krzystek-Korpacka M; Lubeiro A; Stramecki F; Stańczykiewicz B; Beszłej JA; Piotrowski P; Kotowicz K; Szewczuk-Bogusławska M; Pawlak-Adamska E; Misiak B
Brain Behav Immun; 2018 Jul; 71():28-36. PubMed ID: 29730395
[TBL] [Abstract][Full Text] [Related]
10. Psychopathological Symptom Load and Distinguishable Cerebral Blood Flow Velocity Patterns in Patients With Schizophrenia and Healthy Controls: A Functional Transcranial Doppler Study.
Egger ST; Bobes J; Rauen K; Seifritz E; Vetter S; Schuepbach D
Front Psychiatry; 2021; 12():679021. PubMed ID: 34248715
[No Abstract] [Full Text] [Related]
11. Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder.
Karagüzel EÖ; Arslan FC; Uysal EK; Demir S; Aykut DS; Tat M; Karahan SC
Compr Psychiatry; 2019 Feb; 89():61-66. PubMed ID: 30594753
[TBL] [Abstract][Full Text] [Related]
12. Trail making test errors and executive function in schizophrenia and depression.
Mahurin RK; Velligan DI; Hazleton B; Mark Davis J; Eckert S; Miller AL
Clin Neuropsychol; 2006 Jun; 20(2):271-88. PubMed ID: 16690547
[TBL] [Abstract][Full Text] [Related]
13. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.
Hope S; Dieset I; Agartz I; Steen NE; Ueland T; Melle I; Aukrust P; Andreassen OA
J Psychiatr Res; 2011 Dec; 45(12):1608-16. PubMed ID: 21889167
[TBL] [Abstract][Full Text] [Related]
14. Quantitative psychomotor dysfunction in schizophrenia: a loss of drive, impaired movement execution or both?
Docx L; Sabbe B; Provinciael P; Merckx N; Morrens M
Neuropsychobiology; 2013; 68(4):221-7. PubMed ID: 24247207
[TBL] [Abstract][Full Text] [Related]
15. Acute inflammation and psychomotor slowing: Experimental assessment using lipopolysaccharide administration in healthy humans.
Handke A; Axelsson J; Benson S; Boy K; Weskamp V; Hasenberg T; Remy M; Hebebrand J; Föcker M; Brinkhoff A; Unteroberdörster M; Engler H; Schedlowski M; Lasselin J
Brain Behav Immun Health; 2020 Oct; 8():100130. PubMed ID: 34589881
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives.
Flyckt L; Wiesel FA; Borg J; Edman G; Ansved T; Sydow O; Borg K
J Psychiatr Res; 2000; 34(4-5):355-64. PubMed ID: 11104850
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls.
Hope S; Hoseth E; Dieset I; Mørch RH; Aas M; Aukrust P; Djurovic S; Melle I; Ueland T; Agartz I; Ueland T; Westlye LT; Andreassen OA
Schizophr Res; 2015 Jul; 165(2-3):188-94. PubMed ID: 25956633
[TBL] [Abstract][Full Text] [Related]
18. The nature of the relationship of psychomotor slowing with negative symptomatology in schizophrenia.
Bervoets C; Docx L; Sabbe B; Vermeylen S; Van Den Bossche MJ; Morsel A; Morrens M
Cogn Neuropsychiatry; 2014; 19(1):36-46. PubMed ID: 23725330
[TBL] [Abstract][Full Text] [Related]
19. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.
Goldsmith DR; Haroon E; Miller AH; Addington J; Bearden C; Cadenhead K; Cannon T; Cornblatt B; Mathalon D; McGlashan T; Seidman L; Tsuang M; Woods SW; Walker EF; Perkins DO
Brain Behav Immun; 2019 Feb; 76():268-274. PubMed ID: 30496778
[TBL] [Abstract][Full Text] [Related]
20. Psychomotor planning is deficient in recent-onset schizophrenia.
Grootens KP; Vermeeren L; Verkes RJ; Buitelaar JK; Sabbe BG; van Veelen N; Kahn RS; Hulstijn W
Schizophr Res; 2009 Feb; 107(2-3):294-302. PubMed ID: 19008079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
